RecruitingNot a drug-phase studyRelapsing MSNCT07230015

What it found

Still running

No result yet.

What was tested

Treatment tested

  • Motor Imagery + Vestibular Rehabilitation group
  • Conventional therapy group

What it measured

Main measures

  • Change in Cognitive Function (Montreal Cognitive Assessment [MoCA] Score)

    Baseline and 8 weeks after intervention

    Thinking and memory
  • Change in Balance Berg Balance Scale \[ABBS] Score)

    Baseline (Week 0) and Post-intervention (Week 8)

    Walking and mobility
  • Change in Vestibular Function (Dynamic Visual Acuity [DVA] Test)

    Baseline and Week 8.

    VisionWalking and mobility
  • Change in Vestibular Function (Head Impulse Test [HIT])

    Baseline and Week 8

    VisionNerve conduction tests
  • Change in Cognitive Function (Brief International Cognitive Assessment for MS \[BICAMS] Composite Score

    Baseline (Week 0) and Post-intervention (Week 8)

    Thinking and memory
  • Change in balance (Timed Up and Go [TUG] Time)

    Baseline and Week 8

    Walking and mobility
  • Change in Disability Status (Patient-Determined Disease Steps \[PDDS] Score)

    Baseline and Week 8.

Other measures (1)

  • Change in Quality of Life (Multiple Sclerosis Impact Scale-29 \[MSIS-29]

    Baseline and Week 8.

    Quality of life (reported by participants)

Who could take part

Relapsing MS · 18 to 45

inclusion criteria 1. Diagnosis of Multiple Sclerosis (MS) Confirmed using McDonald Criteria 2. Patient diagnosed relapsing-remitting multiple sclerosis (RRMS). 3. Mild MS between 0-3 according to PDDS. 4. Age from (18-45) 5. Mild cognitive impairment 6. Balance impairment (mild to moderate impairment) 7. Vestibular dysfunction Related to MS (dizziness, vertigo , gaze instability ) 8. Native language is Arabic to ensure clear communication during cognitive tasks and exercise instructions 9. Be able to joined the treatment (motor imagery, vestibular rehabilitaiton ) Exclusion Criteria: Other neurological disorder, progressive multiple sclerosis Non-MS related vestibular disorders (e.g., BPPV, Meniere's disease) that would interfere with vestibular rehab. Severe Psychiatric Conditions (schizophrenia, bipolar, etc) Sever balance disorder Sever fatigue Medical instability eg (cardiovascular disease, respiratory, infections, severe uncontrolled diabetes, or severe visual impairments.) Sever cognitive impairment Pregnant Advance disability ( wheelchair , unable to stand ) Use of Vestibular-Suppressing Medications Non - speaker Arabic

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

This trial investigates the first combined use of motor imagery and vestibular rehabilitation in multiple sclerosis, aiming to evaluate their joint effect on balance, cognition, and quality of life.

Papers

Loading reviews and guidelines…

History

    1. Started

      Dec 2025

    2. Main results due

      May 2026

    3. Finished

      Jul 2026

    Assembled by software from public sources and not checked by people. Each record links to its source. Report an error